An analysis of data from two federal government databases showed 54% of US physicians who prescribed opioids to Medicare patients from 2014 to 2015 received payments from opioid makers. Physicians who wrote the most opioid prescriptions were most likely to receive payments from opioid manufacturers, and they also received more money than doctors who wrote fewer opioid prescriptions.
Analysis links opioid Rx volume to payments from drugmakers
Sign up for Specialty Pharmacy SmartBrief
News affecting the specialty pharmacy industry
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.